IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 54.21 USD 0.26%
Market Cap: 686.8m USD
Have any thoughts about
IRadimed Corp?
Write Note

IRadimed Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRadimed Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
IRadimed Corp
NASDAQ:IRMD
Revenue
$71.3m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
16%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%
No Stocks Found

IRadimed Corp
Revenue Breakdown

Breakdown by Geography
IRadimed Corp

Total Revenue: 65.6m USD
100%
United States: 52.5m USD
80.1%
Represents Information Pertaining To Internat...: 13m USD
19.9%

Breakdown by Segments
IRadimed Corp

Not Available

IRadimed Corp
Glance View

Market Cap
686.8m USD
Industry
Health Care

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

IRMD Intrinsic Value
40.87 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is IRadimed Corp's Revenue?
Revenue
71.3m USD

Based on the financial report for Sep 30, 2024, IRadimed Corp's Revenue amounts to 71.3m USD.

What is IRadimed Corp's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for IRadimed Corp have been 23% over the past three years , 15% over the past five years , and 16% over the past ten years .

Back to Top